• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2023 Scientific Session Call For Abstracts
      • 2023 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy-Coming Soon!
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Minimally Invasive Approaches to Congenital Cystic Adenomatoid Malformation

First submitted by:
Danielle Walsh
Category
Chest, Minimally Invasive Surgery, Pediatric Surgery, Thoracic
Print Friendly, PDF & Email

Overview

Congenital cystic adenomatoid malformation (CCAM) is one of a spectrum of congenital pulmonary lesions commonly seen by the pediatric surgeon.  CCAM is characterized by a lack of normal alveolarization with an increased number of terminal bronchioles that are cystic in nature.  These cystic lesions can range from less than 1 mm in size to greater than 10cm.  Based upon the size of the lesions, CCAM’s can be described as macrocystic (lesions greater than 5.0cm) or microcystic radiographically.  While the abnormal bronchioles do not participate in normal gas exchange, they maintain their connection with the normal tracheobronchial tree.1  This communication can lead to overinflation during aggressive attempts at resuscitation in the neonate.  Additionally, inadequate clearing of normal respiratory bacterial pathogen may lead to recurrent pneumonias.1  The latter is the usual delayed presentation of children with CCAM not diagnosed prenatally or in infancy.  Unlike bronchopulmonary sequestration (BPS), CCAM receive only blood supply from the pulmonary artery.  CCAM’s may also show malignant degeneration if left unresected (pulmonary blastoma and rhabdomyosarcoma in infants and young children, bronchoalveolar carcinoma in older children).2

 

Prenatal Diagnosis

CCAM is routinely diagnosed on prenatal ultrasound.  The differential diagnosis includes congenital diaphgramatic hernia, congenital lobar emphysema, bronchopulmonary sequestration, foregut duplication cyst and mediastinal cystic teratoma.  Fetal MRI is used to differentiate between these lesions ultimately allowing for improved prenatal and postnatal care as well as prenatal counseling of the family.3  The size of the CCAM is significant prognostically.  Compression of the esophagus may lead to polyhydramnios due to abnormal fetal swallowing of amniotic fluid.  Compression of the mediastinum by a large CCAM may result in compression of the heart and great vessels ultimately leading to hydrops fetalis.  CCAM volume ratio (CVR) can be determined using prenatal ultrasound by determining the CCAM volume and dividing by the head circumference to standardize for fetal size.  A CVR greater than 1.6 is predictive of increased risk for hydrops.1  CVR can then be useful for determining which CCAM’s require increased level of surveillance prenatally.  CCAM’s reach maximal growth before 28 weeks of gestation.  Following this time period most CCAM’s either plateau in size or regress.1

 

Treatment

Treatment of CCAM is dependent upon the symptoms present.  Prenatal management can consist of steroid treatment in fetuses with a CVR greater than 1.4.  Betamethasone has been shown to arrest growth of CCAM with subsequent improvement in hydrops symptoms.1  A fetus that has been diagnosed with a macrocystic CCAM complicated by hydrops may be treated with thoracoamniotic shunting.  Microcystic or solid CCAM’s that present with hydrops have been approached with fetal surgery.  Late gestation fetus with hydrops may benefit from an ex utero intrapartum therapy (EXIT) approach.1  The fetus with a CCAM without hydrops should be managed with planned delivery and neonatal evaluation and surgery.

All newborns prenatally diagnosed with a CCAM should have a baseline radiograph at the time of birth.  Surgical management should be based upon whether the newborn is symptomatic from the lesion.  Persistent tachypnea, oxygen requirement, poor weight gain and inability to feed orally are indications for immediate resection.  This has been classically performed through a posterolateral thoracotomy.  Asymptomatic children may be discharged and followed up as an outpatient.  At our institution, we typically perform preoperative imaging using computed tomographic scans at 3 months of age.  CCAM’s are typically isolated to a single lobe, however, multilobar CCAM has been documented and will affect surgical decision making.  Surgical resection, through a minimally invasive approach, is then carried out when the infant is 4 to 6 months old.  Children who present with infected lesions are recommended to undergo adequate antibiotic therapy for the infection prior to the lesion.  Minimally invasive approach is still a viable option in children who have had pneumonia; however, there has been a documented increase in conversion to open thoracotomy in these children.4

 

Minimally Invasive Approach     

Preoperative imaging using computed tomographic scanning is obtained at 3 months of age as previously mentioned.  The child should be placed in the lateral decubitus position with the affected side up.  Central venous lines, arterial lines and bladder catheters are not required intraoperatively.  Management of the airway requires an anesthesiologist experienced in pediatric airways to ensure adequate single-lung ventilation.  Techniques available for isolating the contralateral lung include double lumen endotracheal tube in older children and adolescents.  In younger children, a Fogarty balloon catheter (Edwards Lifesciences, Irvine, CA) may be used as an endobronchial blocker with placement of a single-lumen endotracheal tube.  Infants may require mainstem intubation of the contralateral bronchus due to the narrow airway.4  Flexible bronchoscopy is necessary to ensure proper placement of the endotracheal tube and bronchial blocker during initial placement and after repositioning of the patient.  We have not routinely placed epidural catheters preoperatively for pain management.

The surgeon and assistant both stand on the same side of the patient.  We prefer to stand at the front of the patient with the monitor at the patient’s back.  A veress needle is used to enter the chest cavity through a Step radially expanding sheath (USSC, Norwalk, CT).  The hemithorax is then insufflated with low flow, low pressure carbon dioxide to aid in collapse of the affected lung.  We typically preset our insufflations to 1 liter/minute with a pressure of 5 cm H2O.  This initial entry site is typically through the 5th or 6th intercostal space in the mid-axillary line.  Entry at this site will allow for visualization of the major fissure and the underlying pulmonary parenchyma.5  We typically use 3 5mm ports (2 working ports and 1 camera port).  These ports are placed dependent upon the affected lobe and the location of the fissure to ensure adequate triangulation of the ports.  A fourth stab incision for insertion of an instrument to assist with parenchymal retraction.  Local anesthetic is infiltrated at each trocar site.

Resection of CCAM is typically through formal lobectomy.  In the case of multiple CCAM’s affecting multiple lobes, segmental resection may be appropriate to preserve pulmonary parenchyma.  The steps in dissection vary depending upon the affected lobe and follow the same principles as open thoracotomy.6  Completion of the major and minor fissure allows for visualization of the pulmonary vasculature and segmental artery branches.  Division of the arterial branches is followed by division of the pulmonary vein.  Initial division of the pulmonary artery prevents parenchymal congestion and preserves the intrathoracic work space.  The Ligasure (Covidien Energy Devices, Boulder, CO) has proven to be an effective method of dividing pulmonary parenchyma to complete division of the fissure.  This device has also been shown to be an effective method of division of pulmonary vessels.  For larger vessels, control with an endoscopic hemoclip (Auto Suture ENDO CLIP, Covidien) or with intracorporeal suture ligation followed by division using an energy based sealing device has been described.4,7

Following division of the pulmonary vasculature, attention is turned to the segmental bronchus.  In larger children, an endoscopic stapler can be utilized.  In infants we prefer to use a locking hemoclip such as the Hem-o-lok system (Teleflex Medical, Research Triangle Park, NC).  This ensures closure of the bronchus.  The bronchus can also be divided and sutured with a monofilament, absorbable suture.  After division of the bronchus, the specimen can then be removed by enlarging the most inferior trocar site.  We do not routinely utilize an endoscopic pouch for specimen retrieval.  After removal of the specimen an appropriately sized chest tube is placed in the most inferior incision.  All wounds are then closed with absorbable sutures.  The patient is extubated in the operating room and monitored overnight.  We routinely remove the chest tube on the first post-operative day with discharge on the same day.

 

Summary

Thoracoscopic resection of CCAM is a safe alternative to open resection.  Despite longer operative times, the minimally invasive approach has been shown in multiple studies to lead to decreased length of hospital stay, a shorter required time for chest tube and an overall lower postoperative complication rate.8,9,10  Current limitations for a thoracoscopic approach include patient size and inflammation from recurrent pneumonias making dissection more difficult.  Additionally, newborn infants who present with symptomatic lesions are best treated with an open approach.  Thoracoscopy in infants and children can be technically demanding but remains a viable option in the management of CCAM in the pediatric population.

 

References

1) Adzick  NS, Farmer DL:  Cysts of the Lungs and Mediastinum, in Coran AG, Caldamone A, Adzick NS, et al (eds):  Pediatric Surgery, 7th edition, Mosby, 2012.

2) Chiu B, Flake AW:  Congenital Lung Lesions, in Mattei P (ed):  Fundamentals of Pediatric Surgery, Springer, 2011.

3) Pacharn P, Kline-Fath B, Calvo-Garcia M, et al.  Congenital lung lesions:  Prenatal MRI and postnatal findings.  Pediatr Radiol 2013 Sep;43(9):1136-43.

4) Seong YW, Kang CH, Kim JT, et al.  Video-assisted thoracoscopic lobectomy in children:  Safety, efficacy, and risk factors for conversion to thoracotomy.  Ann Thorac Surg 2013;95:1236-42.

5) Rothenberg SS.  First decade’s experience with thoracoscopic lobectomy in infants and children.  J Pediatr Surg 2008;43:40-45.

6) Waldhausen JA, Pierce WS, Campbell DB.  Surgery of the Chest.  St Louis, MO, Mosby Year-Book, 1995.

7) Bignon H, Buela E, Martinez-Ferro M.  Which is the best vessel-sealing method for pediatric thoracoscopic lobectomy?  J Laparoendosc Adv Surg Tech 2010;20(4):395-8

8) Vu LT, Farmer DL, Nobuhara KK, et al.  Thoracoscopic versus open resection for congenital cystic adenomatoid malformations of the lung.  J Pediatr Surg 2008;43:35-39.

9) Albanese CT, Syorak RM, Tsao KJ, et al.  Thoracoscopic lobectomy for prenatally diagnosed lung lesions.  J Pediatr Surg 2003;38:553-55.

10) Koontz CS, Oliva V, Gow KW, et al.  Video-assisted thoracoscopic surgical excision of cystic lung disease in children.  J Pediatr Surg 2005;40:835-37.

 

Robert Ricca, MD

Assistant Professor of Surgery, USUHS

Naval Medical Center

Portsmouth, VA

1,242

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

Category: Chest, Minimally Invasive Surgery, Pediatric Surgery, Thoracic
  • Main Page
  • Help
  • Create a New Wiki

Our Mission

Innovate, educate and collaborate to improve patient care.

Recently, on SAGES…

Critical View of Safety (CVS) Challenge QR Code

The SAGES Critical View of Safety Challenge – Donate Your Lap Chole Videos!

The Society of American Gastrointestinal and Endoscopic Surgeons is hosting the first Artificial Intelligence Data Challenge conducted by surgeons. The aim of this challenge is to generate a large and diverse dataset of laparoscopic cholecystectomy videos, annotated with respect to the subcomponents of the Critical View of Safety (CVS). Computer scientists from all over the […]

Respuesta de SAGES al Estudio NordICC sobre el beneficio de las colonoscopias de detección

SAGES desea aclarar los resultados del estudio NordICC y colocarlos en contexto de los esfuerzos de varias agencias nacionales para reducir el riesgo de cáncer colorrectal – la segunda causa de muerte por cáncer más frecuente en los Estados Unidos-, mediante la promoción de la detección y tratamiento oportuno de las lesiones.

SAGES Response to NordICC Study Regarding Benefit of Screening Colonoscopies

The NordICC Study recently published in The New England Journal of Medicine and widely reported on by media outlets has raised questions regarding the benefit of screening colonoscopy in lowering the risk of colorectal cancer and cancer-related deaths among otherwise healthy and symptom-free men and women aged 55 to 64. Provocative headlines and commentaries have […]

Contact SAGES

Society of American Gastrointestinal and Endoscopic Surgeons
11300 W. Olympic Blvd Suite 600
Los Angeles, CA 90064 USA
webmaster@sages.org
Tel: (310) 437-0544

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons